Illumina stock trades 2.18 percent below its 52-week high
Published on 09/29/2026 at 07:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Illumina stock (ISIN US4523271090) closed at USD 271.90 on Nasdaq on September 28, 2026, leaving the shares 2.18 percent below their 52-week high of USD 277.95. The immediate catalyst was a higher analyst target, with Piper Sandler lifting its price objective to USD 305.00.
Piper target reaches USD 305.00
According to Yahoo Finance on September 28, 2026, Piper Sandler maintained an Overweight rating and raised its Illumina target from USD 225.00 to USD 305.00. The new target lies 12.17 percent above the September 28 price, while the target increase itself amounts to USD 80.00.
The broader valuation picture is less uniform. MarketBeat reported on September 9, 2026, that UBS upgraded Illumina from Neutral to Buy and raised its target from USD 135.00 to USD 260.00. MarketBeat also cited a broader average target of USD 199.12 and a consensus Hold rating, placing the latest market price above that average.
Quarterly beat adds support
Illumina's Q2 FY26 results supplied a second support point. MarketBeat reported revenue of USD 1.16 billion and EPS of USD 1.31, compared with revenue expectations of USD 1.13 billion and EPS consensus of USD 1.23. Revenue increased 9.4 percent from the prior-year quarter, while EPS exceeded consensus by USD 0.08.
Management's fiscal 2026 EPS guidance is USD 5.30-5.40, according to the same September 24 report. That forecast provides a concrete benchmark for the current share price, which has already advanced 107.30 percent year to date through September 28, 2026.
Stock sits near yearly high
The market snapshot shows a USD 88.00 to USD 277.95 52-week range and a market capitalization of USD 41.1 billion as of September 28, 2026. Volume was 2,973,287 shares, compared with a previous close of USD 270.00.
Illumina develops sequencing and array solutions for genetic and genomic analysis across research, healthcare and pharmaceutical applications. wallstreetONLINE lists October 29, 2026 as the next quarterly reporting date.
Illumina stock closes at USD 271.90
Illumina stock closed at USD 271.90 on Nasdaq on September 28, 2026, up 0.70 percent from the previous close and 2.18 percent below its 52-week high.
Illumina stock snapshot
- Company: Illumina, Inc.
- ISIN: US4523271090
- Ticker: ILMN
- Trading venue: Nasdaq
- Closing price (September 28, 2026): USD 271.90
- Market capitalization: USD 41.1 billion (as of September 28, 2026)
- 52-week range: USD 88.00-277.95 (as of September 28, 2026)
- Sector / Industry: Healthcare / Diagnostics and Research
- Next earnings date: October 29, 2026
